-
1
-
-
76549218484
-
Chronic peptic ulcer of the oesophagus and oesophagitis
-
Barrett NR,. Chronic peptic ulcer of the oesophagus and oesophagitis. Br J Surg 1950; 38: 175-82.
-
(1950)
Br J Surg
, vol.38
, pp. 175-182
-
-
Barrett, N.R.1
-
2
-
-
75149134769
-
Barrett's oesophagus and oesophageal adenocarcinoma: Time for a new synthesis
-
Reid BJ, Li X, Galipeau PC, et al,. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 2010; 10: 87-101.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 87-101
-
-
Reid, B.J.1
Li, X.2
Galipeau, P.C.3
-
3
-
-
63949087969
-
Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium
-
Wang A, Mattek NC, Holub JL, et al,. Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium. Dig Dis Sci 2009; 54: 964-71.
-
(2009)
Dig Dis Sci
, vol.54
, pp. 964-971
-
-
Wang, A.1
Mattek, N.C.2
Holub, J.L.3
-
4
-
-
0030040665
-
The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett
-
Spechler SJ, Goyal RK,. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996; 110: 614-21. (Pubitemid 26043897)
-
(1996)
Gastroenterology
, vol.110
, Issue.2
, pp. 614-621
-
-
Spechler, S.J.1
Goyal, R.K.2
-
5
-
-
28844461009
-
Prevalence of Barrett's esophagus in the general population: An endoscopic study
-
DOI 10.1053/j.gastro.2005.08.053, PII S0016508505017713
-
Ronkainen J, Aro P, Storskrubb T, et al,. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005; 129: 1825-31. (Pubitemid 41772961)
-
(2005)
Gastroenterology
, vol.129
, Issue.6
, pp. 1825-1831
-
-
Ronkainen, J.1
Aro, P.2
Storskrubb, T.3
Johansson, S.-E.4
Lind, T.5
Bolling-Sternevald, E.6
Vieth, M.7
Stolte, M.8
Talley, N.J.9
Agreus, L.10
-
6
-
-
0016771074
-
Columnar-lined lower esophagus - Acquired lesion with malignant predisposition - Report on 140 cases of Barretts esophagus with 12 adenocarcinomas
-
Naef AP, Savary M, Ozzello L,. Columnar-lined lower esophagus-acquired lesion with malignant predisposition-report on 140 cases of Barretts esophagus with 12 adenocarcinomas. J Thorac Cardiov Sur 1975; 70: 826-35.
-
(1975)
J Thorac Cardiov sur
, vol.70
, pp. 826-835
-
-
Naef, A.P.1
Savary, M.2
Ozzello, L.3
-
7
-
-
77349099667
-
Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: A systematic review and meta-analysis
-
Sikkema M, de Jonge PJF, Steyerberg EW, et al,. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2010; 8: 235-44.
-
(2010)
Clin Gastroenterol Hepatol
, vol.8
, pp. 235-244
-
-
Sikkema, M.1
De Jonge, P.J.F.2
Steyerberg, E.W.3
-
8
-
-
80054010196
-
Incidence of adenocarcinoma among patients with Barrett's esophagus
-
Hvid-Jensen F, Pedersen L, Drewes AM, et al,. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365: 1375-83.
-
(2011)
N Engl J Med
, vol.365
, pp. 1375-1383
-
-
Hvid-Jensen, F.1
Pedersen, L.2
Drewes, A.M.3
-
9
-
-
79960249713
-
Risk of malignant progression in Barrett's esophagus patients: Results from a large population-based study
-
Bhat S, Coleman HG, Yousef F, et al,. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 2011; 103: 1-9.
-
(2011)
J Natl Cancer Inst
, vol.103
, pp. 1-9
-
-
Bhat, S.1
Coleman, H.G.2
Yousef, F.3
-
10
-
-
0036161377
-
Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus
-
Souza RF, Shewmake K, Terada LS, et al,. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 2002; 122: 299-307. (Pubitemid 34126346)
-
(2002)
Gastroenterology
, vol.122
, Issue.2
, pp. 299-307
-
-
Souza, R.F.1
Shewmake, K.2
Terada, L.S.3
Spechler, S.J.4
-
11
-
-
0035119855
-
Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression
-
DOI 10.1046/j.1365-2036.2001.00939.x
-
Fitzgerald RC, Lascar R, Triadafilopoulos G,. Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression. Aliment Pharmacol Ther 2001; 15: 269-76. (Pubitemid 32187550)
-
(2001)
Alimentary Pharmacology and Therapeutics
, vol.15
, Issue.3
, pp. 269-276
-
-
Fitzgerald, R.C.1
Lascar, R.2
Triadafilopoulos, G.3
-
12
-
-
66149130687
-
Medical treatment of Barrett's esophagus: Can it prevent cancer?
-
Sampliner RE,. Medical treatment of Barrett's esophagus: can it prevent cancer? Surg Oncol Clin N Am 2009; 18: 503-8.
-
(2009)
Surg Oncol Clin N Am
, vol.18
, pp. 503-508
-
-
Sampliner, R.E.1
-
13
-
-
7044232109
-
Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus
-
DOI 10.1111/j.1572-0241.2004.30228.x
-
El-Serag HB, Aguirre TV, Davis S, et al,. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol 2004; 99: 1877-83. (Pubitemid 39421227)
-
(2004)
American Journal of Gastroenterology
, vol.99
, Issue.10
, pp. 1877-1883
-
-
El-Serag, H.B.1
Aguirre, T.V.2
Davis, S.3
Kuebeler, M.4
Bhattacharyya, A.5
Sampliner, R.E.6
-
14
-
-
1942500137
-
Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
-
Hillman LC, Chiragakis L, Shadbolt B, et al,. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Med J Aust 2004; 180: 387-91. (Pubitemid 38528957)
-
(2004)
Medical Journal of Australia
, vol.180
, Issue.8
, pp. 387-391
-
-
Hillman, L.C.1
Chiragakis, L.2
Shadbolt, B.3
Kaye, G.L.4
Clarke, A.C.5
-
15
-
-
33644781586
-
Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: Observations on regression and cancer incidence
-
DOI 10.1111/j.1365-2036.2006.02825.x
-
Cooper BT, Chapman W, Neumann CS, et al,. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther 2006; 23: 727-33. (Pubitemid 43344591)
-
(2006)
Alimentary Pharmacology and Therapeutics
, vol.23
, Issue.6
, pp. 727-733
-
-
Cooper, B.T.1
Chapman, W.2
Neumann, C.S.3
Gearty, J.C.4
-
16
-
-
70849132813
-
Medication usage and the risk of neoplasia in patients with Barrett's esophagus
-
Nguyen DM, El-Serag HB, Henderson L, et al,. Medication usage and the risk of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2009; 7: 1299-304.
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 1299-1304
-
-
Nguyen, D.M.1
El-Serag, H.B.2
Henderson, L.3
-
17
-
-
33750352352
-
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: A nested case control study in the UK
-
DOI 10.1136/gut.2005.086579
-
Rodriguez LAG, Lagergren J, Lindblad M,. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut 2006; 55: 1538-44. (Pubitemid 44629198)
-
(2006)
Gut
, vol.55
, Issue.11
, pp. 1538-1544
-
-
Garcia Rodriguez, L.A.1
Lagergren, J.2
Lindblad, M.3
-
18
-
-
38149050433
-
Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus
-
Hillman LC, Chiragakis L, Shadbolt B, et al,. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus. Aliment Pharmacol Ther 2008; 27: 321-6.
-
(2008)
Aliment Pharmacol Ther
, vol.27
, pp. 321-326
-
-
Hillman, L.C.1
Chiragakis, L.2
Shadbolt, B.3
-
19
-
-
84875365855
-
Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus
-
Kastelein F, Spaander MC, Steyerberg EW, et al,. Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2013; 11: 382-8.
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, pp. 382-388
-
-
Kastelein, F.1
Spaander, M.C.2
Steyerberg, E.W.3
-
20
-
-
33751395235
-
The Danish Civil Registration System. A cohort of eight million persons
-
Pedersen CB, Gotzsche H, Moller JO, et al,. The Danish Civil Registration System-A cohort of eight million persons. Dan Med Bull 2006; 53: 441-9. (Pubitemid 44816920)
-
(2006)
Danish Medical Bulletin
, vol.53
, Issue.4
, pp. 441-449
-
-
Pedersen, C.B.1
Gotzsche, H.2
Moller, J.O.3
Mortensen, P.B.4
-
21
-
-
77953448707
-
Existing data sources for clinical epidemiology: The Danish National Pathology Registry and Data Bank
-
Erichsen R,. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clini Epidemiol 2010; 2: 51-6.
-
(2010)
Clini Epidemiol
, vol.2
, pp. 51-56
-
-
Erichsen, R.1
-
22
-
-
74549129623
-
W. ATC/DDD classification
-
World Health Organization.
-
World Health Organization. W. ATC/DDD classification. WHO Drug Information 2001; 15: 84-8.
-
(2001)
WHO Drug Information
, vol.15
, pp. 84-88
-
-
-
23
-
-
34548566069
-
Proton Pump Inhibitor Use and Risk of Colorectal Cancer: A Population-Based, Case-Control Study
-
DOI 10.1053/j.gastro.2007.06.014, PII S0016508507011559
-
Robertson DJ, Larsson H, Friis S, et al,. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology 2007; 133: 755-60. (Pubitemid 47385871)
-
(2007)
Gastroenterology
, vol.133
, Issue.3
, pp. 755-760
-
-
Robertson, D.J.1
Larsson, H.2
Friis, S.3
Pedersen, L.4
Baron, J.A.5
Sorensen, H.T.6
-
24
-
-
79952288119
-
American Gastroenterological Association medical position statement on the management of Barrett's esophagus
-
Spechler SJ, Sharma P, Souza RF, et al,. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011; 140: 1084-91.
-
(2011)
Gastroenterology
, vol.140
, pp. 1084-1091
-
-
Spechler, S.J.1
Sharma, P.2
Souza, R.F.3
-
25
-
-
84889681189
-
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
-
Fitzgerald RC, di Pietro M, Ragunath K, et al,. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 2014; 63: 7-42.
-
(2014)
Gut
, vol.63
, pp. 7-42
-
-
Fitzgerald, R.C.1
Di Pietro, M.2
Ragunath, K.3
-
26
-
-
77955914922
-
Bile acids are multifunctional modulators of the Barrett's carcinogenesis
-
Burnat G, Majka J, Konturek PC,. Bile acids are multifunctional modulators of the Barrett's carcinogenesis. J Physiol Pharmacol 2010; 61: 185-92.
-
(2010)
J Physiol Pharmacol
, vol.61
, pp. 185-192
-
-
Burnat, G.1
Majka, J.2
Konturek, P.C.3
-
27
-
-
79959378981
-
Systematic review: The role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia
-
McQuaid KR, Laine L, Fennerty MB, et al,. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther 2011; 34: 146-65.
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 146-165
-
-
McQuaid, K.R.1
Laine, L.2
Fennerty, M.B.3
-
28
-
-
84857053733
-
Acid suppression increases rates of Barrett's esophagus and esophageal injury in the presence of duodenal reflux
-
Nasr AO, Dillon MF, Conlon S, et al,. Acid suppression increases rates of Barrett's esophagus and esophageal injury in the presence of duodenal reflux. Surgery 2012; 151: 382-90.
-
(2012)
Surgery
, vol.151
, pp. 382-390
-
-
Nasr, A.O.1
Dillon, M.F.2
Conlon, S.3
-
29
-
-
84861345403
-
Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells
-
Reveiller M, Ghatak S, Toia L, et al,. Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells. Ann Surg 2012; 255: 1113-20.
-
(2012)
Ann Surg
, vol.255
, pp. 1113-1120
-
-
Reveiller, M.1
Ghatak, S.2
Toia, L.3
-
30
-
-
79551632075
-
Effect of proton-pump inhibitor therapy on serum chromogranin a level
-
Pregun I, Herszenyi L, Juhasz M, et al,. Effect of proton-pump inhibitor therapy on serum chromogranin a level. Digestion 2011; 84: 22-8.
-
(2011)
Digestion
, vol.84
, pp. 22-28
-
-
Pregun, I.1
Herszenyi, L.2
Juhasz, M.3
-
31
-
-
67449132488
-
Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation
-
Beales IL, Ogunwobi OO,. Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation. J Mol Endocrinol 2009; 42: 305-18.
-
(2009)
J Mol Endocrinol
, vol.42
, pp. 305-318
-
-
Beales, I.L.1
Ogunwobi, O.O.2
-
32
-
-
56049120292
-
Glycine-extended gastrin stimulates proliferation via JAK2- and Akt-dependent NF-kappaB activation in Barrett's oesophageal adenocarcinoma cells
-
Ogunwobi OO, Beales IL,. Glycine-extended gastrin stimulates proliferation via JAK2- and Akt-dependent NF-kappaB activation in Barrett's oesophageal adenocarcinoma cells. Mol Cell Endocrinol 2008; 296: 94-102.
-
(2008)
Mol Cell Endocrinol
, vol.296
, pp. 94-102
-
-
Ogunwobi, O.O.1
Beales, I.L.2
-
33
-
-
77149170365
-
Long-term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett's oesophagus in vivo
-
Obszynska JA, Atherfold PA, Nanji M, et al,. Long-term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett's oesophagus in vivo. Gut 2010; 59: 156-63.
-
(2010)
Gut
, vol.59
, pp. 156-163
-
-
Obszynska, J.A.1
Atherfold, P.A.2
Nanji, M.3
-
34
-
-
77951977553
-
Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus
-
Wang JS, Varro A, Lightdale CJ, et al,. Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus. Am J Gastroenterol 2010; 105: 1039-45.
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 1039-1045
-
-
Wang, J.S.1
Varro, A.2
Lightdale, C.J.3
-
35
-
-
79953316196
-
Correlation between serum gastrin and cellular proliferation in Barrett's esophagus
-
Green DA, Mlynarczyk CM, Vaccaro BJ, et al,. Correlation between serum gastrin and cellular proliferation in Barrett's esophagus. Therap Adv Gastroenterol 2011; 4: 89-94.
-
(2011)
Therap Adv Gastroenterol
, vol.4
, pp. 89-94
-
-
Green, D.A.1
Mlynarczyk, C.M.2
Vaccaro, B.J.3
-
36
-
-
34548781961
-
Using prescription claims data for drugs available over-the-counter (OTC)
-
DOI 10.1002/pds.1454
-
Yood MU, Campbell UB, Rothman KJ, et al,. Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf 2007; 16: 961-8. (Pubitemid 47422844)
-
(2007)
Pharmacoepidemiology and Drug Safety
, vol.16
, Issue.9
, pp. 961-968
-
-
Yood, M.U.1
Campbell, U.B.2
Rothman, K.J.3
Jick, S.S.4
Lang, J.5
Wells, K.E.6
Jick, H.7
Johnson, C.C.8
-
37
-
-
0037320854
-
Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: A population-based case-control study
-
DOI 10.1161/01.STR.0000054057.11892.5B
-
Johnsen SP, Pedersen L, Friis S, et al,. Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study. Stroke 2003; 34: 387-91. (Pubitemid 36206335)
-
(2003)
Stroke
, vol.34
, Issue.2
, pp. 387-391
-
-
Johnsen, S.P.1
Pedersen, L.2
Friis, So.3
Blot, W.J.4
McLaughlin, J.K.5
Olsen, Jo.H.6
Sorensen, H.T.7
-
38
-
-
0033580405
-
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
-
DOI 10.1056/NEJM199903183401101
-
Lagergren J, Bergstrom R, Lindgren A, et al,. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31. (Pubitemid 29142625)
-
(1999)
New England Journal of Medicine
, vol.340
, Issue.11
, pp. 825-831
-
-
Lagergren, J.1
Bergstrom, R.2
Lindgren, A.3
Nyren, O.4
-
39
-
-
79955938731
-
Proximal and distal esophageal sensitivity is decreased in patients with Barrett's esophagus
-
Krarup AL, Olesen SS, Funch-Jensen P, et al,. Proximal and distal esophageal sensitivity is decreased in patients with Barrett's esophagus. World J Gastroenterol 2011; 17: 514-21.
-
(2011)
World J Gastroenterol
, vol.17
, pp. 514-521
-
-
Krarup, A.L.1
Olesen, S.S.2
Funch-Jensen, P.3
-
40
-
-
77957114279
-
What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis
-
e2.
-
Ford AC, Marwaha A, Lim A, et al,. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis Clin Gastroenterol Hepatol 2010; 8: 830-7.e2.
-
(2010)
Clin Gastroenterol Hepatol
, vol.8
, pp. 830-837
-
-
Ford, A.C.1
Marwaha, A.2
Lim, A.3
-
41
-
-
77949262976
-
Dyspeptic symptoms and endoscopic findings in the community: The Loiano-Monghidoro Study
-
Zagari RM, Law GR, Fuccio L, et al,. Dyspeptic symptoms and endoscopic findings in the community: the Loiano-Monghidoro Study. Am J Gastroenterol 2009; 105: 565-71.
-
(2009)
Am J Gastroenterol
, vol.105
, pp. 565-571
-
-
Zagari, R.M.1
Law, G.R.2
Fuccio, L.3
-
42
-
-
33745195704
-
Gastro-oesophageal reflux disease
-
Moayyedi P, Talley NJ,. Gastro-oesophageal reflux disease. Lancet 2006; 367: 2086-100.
-
(2006)
Lancet
, vol.367
, pp. 2086-2100
-
-
Moayyedi, P.1
Talley, N.J.2
|